A report on neurogenic bladder in COVID-19 vaccine-associated acute transverse myelitis

Introduction: Acute transverse myelitis (ATM) is a rare neurological complication of Coronavirus disease (COVID-19) vaccines. Various vaccines have been linked to ATM, such as non-replicating viral vectors, ribonucleic acid, and inactivated vaccines. An ATM case is presented here involving the BNT16...

Full description

Bibliographic Details
Published in:Spinal Cord Series and Cases
Main Author: Zainudin M.F.; Hasim M.R.; Martin C.E.; Chandrabose T.
Format: Article
Language:English
Published: Springer Nature 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85191343034&doi=10.1038%2fs41394-024-00642-5&partnerID=40&md5=45176fbe636ddb5d5714de236d9a02da
id 2-s2.0-85191343034
spelling 2-s2.0-85191343034
Zainudin M.F.; Hasim M.R.; Martin C.E.; Chandrabose T.
A report on neurogenic bladder in COVID-19 vaccine-associated acute transverse myelitis
2024
Spinal Cord Series and Cases
10
1
10.1038/s41394-024-00642-5
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85191343034&doi=10.1038%2fs41394-024-00642-5&partnerID=40&md5=45176fbe636ddb5d5714de236d9a02da
Introduction: Acute transverse myelitis (ATM) is a rare neurological complication of Coronavirus disease (COVID-19) vaccines. Various vaccines have been linked to ATM, such as non-replicating viral vectors, ribonucleic acid, and inactivated vaccines. An ATM case is presented here involving the BNT162b2 vaccine leading to asymmetrical incomplete paraplegia and neurogenic bladder. Case presentation: A 66-year-old male developed urinary retention one day after his second dose of the BNT162b2 vaccine, followed by rapidly progressing lower limb weakness. Clinical examination showed asymmetrical paraparesis, reduced sensation below the T8 level, including perianal sensation, and loss of ankle and anal reflexes. Laboratory tests were largely unremarkable, while the spine MRI revealed thickened conus medullaris with a mild increase in T2/STIR signal intensity and subtle enhancement post gadolinium. Following treatment with methylprednisolone, plasmapheresis, and immunoglobulin, and a rehabilitation program, the patient achieved good motor and sensory recovery, but the bladder dysfunction persisted. Single-channel cystometry indicated neurogenic detrusor underactivity and reduced bladder sensation, as evidenced by low-pressure and compliant bladder. The urethral sphincter appeared intact or overactive. The post-void residual urine was significant, necessitating prolonged intermittent catheterisation. Discussion: Bladder dysfunction due to the COVID-19 vaccine-associated ATM is not as commonly reported as motor or sensory deficits. To our knowledge, this is the first case to highlight a neurogenic bladder that necessitates prolonged intermittent catheterisation as a consequence of COVID-19 vaccine-associated ATM. This report highlights the rare complication of the neurogenic bladder resulting from the BNT162b2 vaccine. Early detection and treatment are crucial to prevent long-term complications. © The Author(s), under exclusive licence to International Spinal Cord Society 2024.
Springer Nature
20586124
English
Article

author Zainudin M.F.; Hasim M.R.; Martin C.E.; Chandrabose T.
spellingShingle Zainudin M.F.; Hasim M.R.; Martin C.E.; Chandrabose T.
A report on neurogenic bladder in COVID-19 vaccine-associated acute transverse myelitis
author_facet Zainudin M.F.; Hasim M.R.; Martin C.E.; Chandrabose T.
author_sort Zainudin M.F.; Hasim M.R.; Martin C.E.; Chandrabose T.
title A report on neurogenic bladder in COVID-19 vaccine-associated acute transverse myelitis
title_short A report on neurogenic bladder in COVID-19 vaccine-associated acute transverse myelitis
title_full A report on neurogenic bladder in COVID-19 vaccine-associated acute transverse myelitis
title_fullStr A report on neurogenic bladder in COVID-19 vaccine-associated acute transverse myelitis
title_full_unstemmed A report on neurogenic bladder in COVID-19 vaccine-associated acute transverse myelitis
title_sort A report on neurogenic bladder in COVID-19 vaccine-associated acute transverse myelitis
publishDate 2024
container_title Spinal Cord Series and Cases
container_volume 10
container_issue 1
doi_str_mv 10.1038/s41394-024-00642-5
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85191343034&doi=10.1038%2fs41394-024-00642-5&partnerID=40&md5=45176fbe636ddb5d5714de236d9a02da
description Introduction: Acute transverse myelitis (ATM) is a rare neurological complication of Coronavirus disease (COVID-19) vaccines. Various vaccines have been linked to ATM, such as non-replicating viral vectors, ribonucleic acid, and inactivated vaccines. An ATM case is presented here involving the BNT162b2 vaccine leading to asymmetrical incomplete paraplegia and neurogenic bladder. Case presentation: A 66-year-old male developed urinary retention one day after his second dose of the BNT162b2 vaccine, followed by rapidly progressing lower limb weakness. Clinical examination showed asymmetrical paraparesis, reduced sensation below the T8 level, including perianal sensation, and loss of ankle and anal reflexes. Laboratory tests were largely unremarkable, while the spine MRI revealed thickened conus medullaris with a mild increase in T2/STIR signal intensity and subtle enhancement post gadolinium. Following treatment with methylprednisolone, plasmapheresis, and immunoglobulin, and a rehabilitation program, the patient achieved good motor and sensory recovery, but the bladder dysfunction persisted. Single-channel cystometry indicated neurogenic detrusor underactivity and reduced bladder sensation, as evidenced by low-pressure and compliant bladder. The urethral sphincter appeared intact or overactive. The post-void residual urine was significant, necessitating prolonged intermittent catheterisation. Discussion: Bladder dysfunction due to the COVID-19 vaccine-associated ATM is not as commonly reported as motor or sensory deficits. To our knowledge, this is the first case to highlight a neurogenic bladder that necessitates prolonged intermittent catheterisation as a consequence of COVID-19 vaccine-associated ATM. This report highlights the rare complication of the neurogenic bladder resulting from the BNT162b2 vaccine. Early detection and treatment are crucial to prevent long-term complications. © The Author(s), under exclusive licence to International Spinal Cord Society 2024.
publisher Springer Nature
issn 20586124
language English
format Article
accesstype
record_format scopus
collection Scopus
_version_ 1809677880375902208